Shanghai Medicilon (SHSE:688202) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 28, 2026)


SHSE:688202 Shanghai Medicilon Inc SHSE:688202
73 GF Score
Price ¥70.57
GF Value ¥46.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Medicilon Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Medicilon's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688202 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Shanghai Medicilon's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Medicilon Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's Margin of Safety % (DCF FCF Based) falls into.


SHSE:688202
73GF Score
Shanghai Medicilon Inc SHSE:688202
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Medicilon (SHSE:688202) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Medicilon stock appears to be overvalued. The current stock price of ¥70.57 is trading 53% above its estimated GF Value™ of ¥46.13. GuruFocus considers Shanghai Medicilon to be Significantly Overvalued.

Key valuation signals for SHSE:688202:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥46.13 vs. price of ¥70.57 (53% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Medicilon Business Description

Address Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
73GF Score

Get the complete analysis for SHSE:688202

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥70.57
Price
¥46.13
GF Value